Last updated on December 2018

Phase 1/2 Study Exploring the Safety Tolerability and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies


Brief description of study

The purpose of this study is to determine the safety, tolerability, and efficacy of INCAGN01876 when given in combination with immune therapies in subjects with advanced or metastatic malignancies.

Clinical Study Identifier: NCT03126110

Contact Investigators or Research Sites near you

Start Over

Dr. Laura Layos Romero

Institut Catala D'Oncologia-Badalona
Barcelona, Spain
9.57miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.